[1. M. S. Tallman, D. G. Gilliland and J. M. Rowe, Drug therapy for acute myeloid leukemia, Blood106 (2005) 1154–1163; https://doi.org/10.1182/blood-2005-01-017810.1182/blood-2005-01-0178]Search in Google Scholar
[2. E. Estey and H. Dohner, Acute myeloid leukaemia, Lancet368 (2006) 1894–1907; https://doi.org/10.1016/S0140-6736(06)69780-810.1016/S0140-6736(06)69780-8]Search in Google Scholar
[3. J. Mao, S. Li, H. Zhao, Y. Zhu, M. Hong, H. Zhu, S. Qian and J. Li, Effects of chidamide and its combination with decitabine on proliferation and apoptosis of leukemia cell lines, Am. J. Transl. Res.10 (2018) 2567–2578.]Search in Google Scholar
[4. E. Jabbour, D. Thomas, J. Cortes, H. M. Kantarjian and S. O’Brien, Central nervous system prophylaxis in adults with acute lymphoblastic leukemia: current and emerging therapies, Cancer116 (2010) 2290–300; https://doi.org/10.1002/cncr.2500810.1002/cncr.2500820209620]Search in Google Scholar
[5. M. D. Kraszewska, M. Dawidowska, T. Szczepański and M. Witt, T-cell acute lymphoblastic leukaemia: recent molecular biology findings, Br. J. Haematol.156 (2015) 303–15; https://doi.org/10.1111/j.1365-2141.2011.08957.x10.1111/j.1365-2141.2011.08957.x22145858]Search in Google Scholar
[6. R. Valentin, S. Grabow and M. S. Davids, The rise of apoptosis: Targeting apoptosis in hemato-logic malignancies, Blood132 (2018) 1248–1264; https://doi.org/10.1182/blood-2018-02-79135010.1182/blood-2018-02-79135030012635]Search in Google Scholar
[7. K. Durinck, S. Goossens, S. Peirs, A. Wallaert, W. Van Loocke, F. Matthijssens, T. Pieters, G. Milani, T. Lammens, P. Rondou and N. Van Roy, Novel biological insights in T-cell acute lymphoblastic leukemia, Exp. Hematol.43 (2015) 625–639; https://doi.org/10.1016/j.exphem.2015.05.01710.1016/j.exphem.2015.05.01726123366]Search in Google Scholar
[8. S. H. Kang, S. J. Jeong, S. H. Kim, J. H. Kim, J. H. Jung, W. Koh, J. H. Kim, D. K. Kim, C. Y. Chen and S. H. Kim, Icariside II induces apoptosis in U937 acute myeloid leukemia cells: Role of inactivation of STAT3-related signaling, PLOS One7 (2012) e28706; https://doi.org/10.1371/journal.pone.002870610.1371/journal.pone.0028706332088722493659]Search in Google Scholar
[9. Y. Küley-Bagheri, K. A. Kreuzer, I. Monsef, M. Lübbert and N. Skoetz, Effects of all-trans retinoic acid (ATRA) in addition to chemotherapy for adults with acute myeloid leukaemia (AML) (non-acute promyelocytic leukaemia (non-APL), Cochrane Database of Systematic Reviews8 (2018) Cd011960; https://doi.org/10.1002/14651858.CD011960.pub210.1002/14651858.CD011960.pub2651362830080246]Search in Google Scholar
[10. L. Mei, E. P. Ontiveros, E. A. Griffiths, J. E. Thompson, E. S. Wang and M. Wetzler, Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapy, Blood Rev. 29 (2015) 243–249; https://doi.org/10.1016/j.blre.2015.01.00110.1016/j.blre.2015.01.001449487025614322]Search in Google Scholar
[11. S. Samala and C. Veerasham, Ehanced bioavalibity of glimepiride in the presence of boswellic acids in streptozotocin-induced diabetic rat model, Nat. Prod. Chem. Res. 1 (2013) 116.]Search in Google Scholar
[12. S. G. D. Oliveira, E. Piva and R. G, Lund The PO possibility of Interactions between medicinal herbs and allopathic medicines used by patients attended at basic care units of the Brazilian unified health system, Nat. Prod. Chem. Res.3 (2015) 171; http://dx.doi.org/10.4172/2329-6836.100017110.4172/2329-6836.1000171]Search in Google Scholar
[13. G. M. Cragg and D. J. Newman, Biodiversity: A continuing source of novel drug leads, Pure Appl. Chem. 77 (2005) 7–24.]Search in Google Scholar
[14. C. Kim and B. Kim, Anti-cancer natural products and their bioactive compounds inducing ER stress-mediated apoptosis: A Review, Nutrients10 (2018) 1021; https://doi.org/10.3390/nu1008102110.3390/nu10081021]Search in Google Scholar
[15. R. A. Maplestone, M. J. Stone and D. H. Williams, The evolutionary role of secondary metabolites-A review, Gene115 (1992) 151–157; https://doi.org/10.1016/0378-1119(92)90553-210.1016/0378-1119(92)90553-2]Search in Google Scholar
[16. S. Russmann, B. H. Lauterburg, Y. Barguil, E. Choblet, P. Cabalion, K. Rentsch and M. Wenk, Traditional aqueous kava extracts inhibit cytochrome P450 1A2 in humans: protective effect against environmental carcinogens, Clin. Pharmacol. Ther.77 (2005) 453–454; https://doi.org/10.1016/j.clpt.2005.01.02110.1016/j.clpt.2005.01.021]Search in Google Scholar
[17. Y. Ma, K. Sachdeva, J. Liu, M. Ford, D. Yang, I. A. Khan, C. O. Chichester and B. Yan, Desmethoxyyangonin and dihydromethysticin are two major pharmacological kavalactones with marked activity on the induction of CYP3A23, Drug. Metab. Dispos.32 (2004) 1317–1324; https://doi.org/10.1124/dmd.104.00078610.1124/dmd.104.000786]Search in Google Scholar
[18. J. Walden, J. von Wegerer, U. Winter, M. Berger and H. Grunze H, Effects of kawain and dihydromethysticin on field potential changes in the hippocampus, Prog. Neuro-Psychopharmacol. Biol. Psychiatry21 (1997) 697–706.10.1016/S0278-5846(97)00042-0]Search in Google Scholar
[19. J. Sarris, E. Laporte and I. Schweitzer, Kava: A comprehensive review of efficacy, safety, and psycho-pharmacology, Aust. N. Z. J. Psychiatry45 (2011) 27–35; https://doi.org/10.3109%2F00048674.2010.522554]Search in Google Scholar
[20. Y. N. Singh and N. N. Singh, Therapeutic potential of kava in the treatment of anxiety disorders, Mol. Diag. Ther.16 (2002) 731–743; https://doi.org/10.2165/00023210-200216110-0000210.2165/00023210-200216110-0000212383029]Search in Google Scholar
[21. J. Q. Dai, Y. G Huang and A. N. He, Dihydromethysticin kavalactone induces apoptosis in osteosarcoma cells through modulation of PI3K/Akt pathway, disruption of mitochondrial membrane potential and inducing cell cycle arrest, Int. J. Clin. Exp. Pathol.8 (2015) 4356–4366.]Search in Google Scholar
[22. H. Pan, F. Liu, J. Wang, et al. Dihydromethysticin, a natural molecule from Kava, suppresses the growth of colorectal cancer via the NLRC3/PI3K pathway, Mol. Carcinog. 59 (2020) 575–589; https://doi.org/10.1002/mc.2318210.1002/mc.2318232187756]Search in Google Scholar
[23. M. D. Megonigal, E. F. Rappaport, D. H. Jones, C. S. Kim, P. C. Nowell, B. J. Lange and C. A. Felix, Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias, Proc. Natl. Acad. Sci.94 (1997) 11583–11588; https://doi.org/10.1073/pnas.94.21.1158310.1073/pnas.94.21.11583235469326653]Search in Google Scholar
[24. A. S. Sreedhar and P. Csermely, Heat shock proteins in the regulation of apoptosis: new strategies in tumor therapy: a comprehensive review, Pharmacol. Ther.101 (2004) 227–257; https://doi.org/10.1016/j.pharmthera.2003.11.00410.1016/j.pharmthera.2003.11.00415031001]Search in Google Scholar
[25. K. Zhang, A. N. Ezemaduka, Z. Wang, H. Hu, X. Shi, C. Liu, X. Lu, X. Fu, Z. Chang and C. C. Yin, A novel mechanism for small heat shock proteins to function as molecular chaperones, Sci. Rep.5 (2015) 8811; https://doi.org/10.1038/srep0881110.1038/srep08811435154925744691]Search in Google Scholar
[26. W. Tang and G. Zhao, Small molecules targeting HIF-1α pathway for cancer therapy in recent years, Bioorg. Med. Chem.332 (2013) 275–285; https://doi.org/10.1016/j.bmc.2019.11523510.1016/j.bmc.2019.11523531843464]Search in Google Scholar
[27. A.O. Oyewole, M. C. Wilmot, M. Fowler and M. A. Birch-Machin, Comparing the effects of mitochondrial targeted and localized antioxidants with cellular antioxidants in human skin cells exposed to UVA and hydrogen peroxide, FASEB J.28 (2014) 485–494; https://doi.org/10.1096/fj.13-23700810.1096/fj.13-23700824115050]Search in Google Scholar
[28. F. Wang, X. Ye, D. Zhai, W. Dai, Y. Wu, J. Chen and W. Chen, Curcumin-loaded nanostructured lipid carrier induced apoptosis in human HepG2 cells through activation of the DR5/caspase-mediated extrinsic apoptosis pathway, Acta Pharm. 70 (2020) 227–237; https://doi.org/10.2478/acph-2020-000310.2478/acph-2020-000331955141]Search in Google Scholar
[29. F. Seif, M. Khoshmirsafa, H. Aazami, M. Mohsenzadegan, G. Sedighi and M. Bahar, The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells, Cell Commun. Signal.15 (2017) 23; https://doi.org/10.1186/s12964-017-0177-y10.1186/s12964-017-0177-y548018928637459]Search in Google Scholar